Stifel Expands European Tech & Healthcare Presence with Bryan Garnier Acquisition
Stifel Financial Corp. (NYSE: SF) announced it has signed a definitive agreement to acquire Bryan, Garnier & Co., a leading independent investment bank focused on European technology and healthcare companies.
Founded in 1996, Bryan Garnier offers mergers & acquisitions advisory, private and public growth financing solutions, and institutional sales & execution. The firm has approximately 200 professionals, including 33 Managing Directors, and operates from offices in Paris, London, Amsterdam, Munich, Oslo, Stockholm, and New York.
Stifel’s CEO, Ronald J. Kruszewski, stated that Bryan Garnier’s expertise in healthcare and technology aligns well with Stifel’s business, enhancing its global advisory capabilities. Olivier Garnier, co-founder of Bryan Garnier, highlighted the combined benefits for clients, employees, and the European market.
Stifel, which is expected to generate over $4.8 billion in net revenue in 2024, has been expanding through acquisitions and organic growth. The company employs nearly 10,000 professionals across approximately 400 offices worldwide. Keefe, Bruyette & Woods acted as the exclusive financial advisor to Stifel, while Houlihan Lokey advised Bryan Garnier.
Stifel Financial Corp. (NYSE: SF) ha annunciato di aver firmato un accordo definitivo per acquisire Bryan, Garnier & Co., una delle principali banche d’investimento indipendenti focalizzata su società tecnologiche e sanitarie europee.
Fondata nel 1996, Bryan Garnier offre servizi di consulenza per fusioni e acquisizioni, soluzioni di finanziamento per crescita privata e pubblica, e vendite ed esecuzioni istituzionali. L’azienda conta circa 200 professionisti, inclusi 33 Direttori Generali, e opera da uffici a Parigi, Londra, Amsterdam, Monaco, Oslo, Stoccolma e New York.
Il CEO di Stifel, Ronald J. Kruszewski, ha dichiarato che l’expertise di Bryan Garnier nei settori della sanità e della tecnologia si allinea bene con il business di Stifel, migliorando le sue capacità di consulenza globale. Olivier Garnier, cofondatore di Bryan Garnier, ha sottolineato i vantaggi combinati per clienti, dipendenti e il mercato europeo.
Stifel, che si prevede genererà oltre 4,8 miliardi di dollari di ricavi netti nel 2024, ha continuato ad espandersi attraverso acquisizioni e crescita organica. L’azienda impiega quasi 10.000 professionisti in circa 400 uffici in tutto il mondo. Keefe, Bruyette & Woods ha agito come consulente finanziario esclusivo di Stifel, mentre Houlihan Lokey ha consigliato Bryan Garnier.
Stifel Financial Corp. (NYSE: SF) anunció que ha firmado un acuerdo definitivo para adquirir Bryan, Garnier & Co., un destacado banco de inversión independiente enfocado en empresas de tecnología y salud en Europa.
Fundada en 1996, Bryan Garnier ofrece asesoría en fusiones y adquisiciones, soluciones de financiamiento para crecimiento privado y público, así como ventas y ejecución institucional. La firma cuenta con aproximadamente 200 profesionales, incluidos 33 Directores Generales, y opera desde oficinas en París, Londres, Ámsterdam, Múnich, Oslo, Estocolmo y Nueva York.
El CEO de Stifel, Ronald J. Kruszewski, declaró que la experiencia de Bryan Garnier en los sectores de salud y tecnología se alinea perfectamente con el negocio de Stifel, mejorando sus capacidades de asesoría global. Olivier Garnier, cofundador de Bryan Garnier, destacó los beneficios combinados para los clientes, empleados y el mercado europeo.
Stifel, que se espera genere más de 4.8 mil millones de dólares en ingresos netos en 2024, ha estado expandiéndose a través de adquisiciones y crecimiento orgánico. La empresa emplea a casi 10,000 profesionales en aproximadamente 400 oficinas en todo el mundo. Keefe, Bruyette & Woods actuó como asesor financiero exclusivo de Stifel, mientras que Houlihan Lokey asesoró a Bryan Garnier.
Stifel Financial Corp. (NYSE: SF)는 유럽의 기술 및 의료 회사에 초점을 맞춘 독립적인 투자은행인 Bryan, Garnier & Co.를 인수하는 최종 계약을 체결했다고 발표했습니다.
1996년에 설립된 Bryan Garnier는 인수 합병 자문, 민간 및 공개 성장 자금 조달 솔루션, 그리고 기관 세일즈 및 실행 서비스를 제공합니다. 이 회사는 약 200명의 전문가를 고용하고 있으며, 그 중 33명이 상무이사입니다. 파리, 런던, 암스테르담, 뮌헨, 오슬로, 스톡홀름, 뉴욕에 사무소를 두고 있습니다.
Stifel의 CEO인 Ronald J. Kruszewski는 Bryan Garnier의 헬스케어와 기술 분야의 전문성이 Stifel의 비즈니스와 잘 맞아 글로벌 자문 능력을 강화한다고 밝혔습니다. Bryan Garnier의 공동 창립자인 Olivier Garnier는 고객, 직원 및 유럽 시장을 위한 융합된 이점을 강조했습니다.
Stifel은 2024년에 48억 달러 이상의 순수익을 창출할 것으로 예상되며, 인수 및 유기적 성장을 통해 확장하고 있습니다. 이 회사는 전 세계 약 400개의 사무소에서 거의 10,000명의 전문가를 고용하고 있습니다. Keefe, Bruyette & Woods는 Stifel의 독점 재무 자문 역할을 했고, Houlihan Lokey는 Bryan Garnier를 자문했습니다.
Stifel Financial Corp. (NYSE: SF) a annoncé avoir signé un accord définitif pour acquérir Bryan, Garnier & Co., une banque d’investissement indépendante de premier plan axée sur les entreprises technologiques et de santé européennes.
Fondée en 1996, Bryan Garnier offre des conseils en fusions et acquisitions, des solutions de financement pour la croissance privée et publique, ainsi que des ventes et exécutions institutionnelles. L’entreprise compte environ 200 professionnels, dont 33 Directeurs Généraux, et dispose de bureaux à Paris, Londres, Amsterdam, Munich, Oslo, Stockholm et New York.
Le PDG de Stifel, Ronald J. Kruszewski, a déclaré que l’expertise de Bryan Garnier dans le domaine de la santé et de la technologie s’aligne bien avec les activités de Stifel, améliorant ainsi ses capacités de conseil global. Olivier Garnier, cofondateur de Bryan Garnier, a souligné les avantages combinés pour les clients, les employés et le marché européen.
Stifel, qui devrait générer plus de 4,8 milliards de dollars de revenus nets en 2024, s’est développé par le biais d’acquisitions et d’une croissance organique. L’entreprise emploie près de 10 000 professionnels dans environ 400 bureaux à travers le monde. Keefe, Bruyette & Woods a agi en tant que conseiller financier exclusif pour Stifel, tandis que Houlihan Lokey a conseillé Bryan Garnier.
Stifel Financial Corp. (NYSE: SF) hat angekündigt, eine endgültige Vereinbarung zum Erwerb von Bryan, Garnier & Co. zu unterzeichnen, einer führenden unabhängigen Investmentbank, die sich auf europäische Technologie- und Gesundheitsunternehmen spezialisiert hat.
Gegründet im Jahr 1996 bietet Bryan Garnier Beratungsdienste für Fusionen und Übernahmen, private und öffentliche Wachstumsfinanzierungslösungen sowie institutionelle Verkäufe und Ausführung. Die Firma beschäftigt etwa 200 Fachleute, darunter 33 Geschäftsführer, und hat Büros in Paris, London, Amsterdam, München, Oslo, Stockholm und New York.
Der CEO von Stifel, Ronald J. Kruszewski, erklärte, dass die Expertise von Bryan Garnier im Gesundheits- und Technologiesektor gut zu Stifels Geschäft passt, wodurch die globalen Beratungsfähigkeiten verbessert werden. Olivier Garnier, Mitbegründer von Bryan Garnier, hob die kombinierten Vorteile für Kunden, Mitarbeiter und den europäischen Markt hervor.
Stifel, das voraussichtlich 2024 über 4,8 Milliarden Dollar Nettoumsatz generieren wird, hat sich durch Akquisitionen und organisches Wachstum erweitert. Das Unternehmen beschäftigt fast 10.000 Fachleute in etwa 400 Büros weltweit. Keefe, Bruyette & Woods fungierte als exklusiver Finanzberater für Stifel, während Houlihan Lokey Bryan Garnier beriet.
Positive
- The acquisition expands Stifel’s footprint in the European healthcare and technology sectors.
- Bryan Garnier brings a team of 200 professionals, including 33 Managing Directors, enhancing Stifel’s advisory capabilities.
- Stifel is on pace to generate over $4.8 billion in net revenue in 2024, indicating strong financial performance.
Negative
- Terms of the transaction were not disclosed, leaving investors uncertain about the financial impact.
Insights
This strategic acquisition significantly strengthens Stifel’s European presence in two important verticals – healthcare and technology. Bryan Garnier’s addition of 33 Managing Directors and 200 professionals across major European financial hubs will substantially boost Stifel’s cross-border M&A capabilities and deal flow. Based on Stifel’s projected
The deal’s timing is particularly strategic given the increasing demand for healthcare and technology investment banking services in Europe. Bryan Garnier’s established relationships with European growth companies complement Stifel’s strong US presence, creating a more robust transatlantic platform. While financial terms weren’t disclosed, Bryan Garnier’s expertise in private and public growth financing solutions will likely contribute meaningfully to Stifel’s revenue diversification.
The transaction’s structure reveals careful strategic positioning. By acquiring a full-service investment bank with deep sector expertise rather than just adding personnel, Stifel gains immediate market credibility and established client relationships across key European markets. The involvement of top-tier advisors – KBW and Houlihan Lokey – suggests a complex valuation process, likely involving earnout provisions and retention mechanisms for key personnel.
The regulatory implications are noteworthy – this acquisition will require approvals from multiple European financial regulators, given Bryan Garnier’s presence across Paris, London, Amsterdam, Munich, Oslo and Stockholm. The post-Brexit landscape makes this particularly relevant for operations spanning both EU and UK jurisdictions.
This acquisition positions Stifel to capitalize on Europe’s growing healthcare and technology sectors, where deal activity remains robust despite broader market volatility. The European investment banking landscape has seen significant consolidation, with mid-market firms particularly active in cross-border transactions. Bryan Garnier’s focus on growth companies aligns perfectly with current market trends showing increased demand for specialized sector expertise in middle-market deals.
The deal will likely accelerate Stifel’s European revenue growth, particularly in advisory fees and equity capital markets. The combined entity’s enhanced capability to execute cross-border transactions should drive higher deal values and increased market share in the competitive European investment banking space.
Expands European Advisory Footprint in Healthcare & Technology Verticals
ST. LOUIS and PARIS, Jan. 06, 2025 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today announced it has signed a definitive agreement to acquire Bryan, Garnier & Co. (“Bryan Garnier”), a leading independent full-service investment bank focused on European technology and healthcare companies. Terms of the transaction were not disclosed.
Founded in 1996, Bryan Garnier’s product suite includes mergers & acquisitions advisory, private and public growth financing solutions and institutional sales & execution. With a team of approximately 200 professionals, including 33 Managing Directors, Bryan Garnier is headquartered in Paris and has offices in London, Amsterdam, Munich, Oslo, Stockholm, and New York.
“As a leading European middle market investment bank in the healthcare and technology verticals, Bryan Garnier represents an ideal partner,” said Ronald J. Kruszewski, Stifel Chairman and CEO. “Its culture and long-term history of providing clients with high quality advice in two of our largest investment banking growth verticals is highly complementary with Stifel’s business. This combination is a logical next step in the evolution of Stifel’s global advisory business.”
“By integrating Stifel’s capabilities across advisory, private and public markets, and equity and debt solutions, Stifel and Bryan Garnier are offering unparalleled opportunities for clients, employees, and the European market as a whole,” said Olivier Garnier, co-founder and Managing Partner of Bryan Garnier.
Over the years, Stifel has grown both organically and through acquisition, and is on pace to generate more than
Keefe, Bruyette & Woods, A Stifel Company, acted as exclusive financial advisor and Bryan Cave Leighton Paisner LLP acted as legal advisor to Stifel in the transaction. Houlihan Lokey acted as exclusive financial advisor and White & Case LLP acted as legal advisor to Bryan Garnier.
*Based on YTD annualized net revenue through 9/30/24
Stifel Company Information
Stifel Financial Corp. (NYSE: SF) is a financial services holding company headquartered in St. Louis, Missouri, that conducts its banking, securities, and financial services business through several wholly owned subsidiaries. Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners and Miller Buckfire business divisions; Keefe, Bruyette & Woods, Inc.; and Stifel Independent Advisors, LLC; in Canada through Stifel Nicolaus Canada Inc.; and in the United Kingdom and Europe through Stifel Nicolaus Europe Limited. The Company’s broker-dealer affiliates provide securities brokerage, investment banking, trading, investment advisory, and related financial services to individual investors, professional money managers, businesses, and municipalities. Stifel Bank and Stifel Bank & Trust offer a full range of consumer and commercial lending solutions. Stifel Trust Company, N.A. and Stifel Trust Company Delaware, N.A. offer trust and related services. To learn more about Stifel, please visit the Company’s website at www.stifel.com. For global disclosures, please visit https://www.stifel.com/investor-relations/press-releases.
About Bryan, Garnier & Co
Bryan, Garnier & Co is a European growth investment bank that helps healthcare and technology companies become global champions. By combining extensive sector expertise with an entrepreneurial mindset, Bryan Garnier provides companies and their investors with independent growth strategic advice, and privileged access to buyers and capital in Europe, the US and Asia. As a full-service investment bank, the firm offering includes private and public growth financing solutions, mergers and acquisitions (M&A) advisory, research insights, and institutional sales & execution. Founded in 1996, Bryan Garnier & Co is an independent partnership with around 200 employees located in major financial centers in Europe and the US.
Cautionary Note Regarding Forward-Looking Statements
The information contained in this press release contains certain statements that may be deemed to be “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements in this report not dealing with historical results are forward-looking and are based on various assumptions. The forward-looking statements in this report are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in or implied by the statements. Material factors and assumptions could cause actual results to differ materially from current expectations. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made. The Company disclaims any intent or obligation to update these forward-looking statements.
Media Contact:
Neil Shapiro, +1 (212) 271-3447
shapiron@stifel.com
Investor Relations Contact:
Joel Jeffrey, +1 (212) 271-3610
investorrelations@stifel.com
FAQ
What is the significance of Stifel’s acquisition of Bryan Garnier?
The acquisition expands Stifel’s advisory footprint in European healthcare and technology sectors, enhancing its global capabilities.
How many professionals are joining Stifel from Bryan Garnier?
Approximately 200 professionals, including 33 Managing Directors, will join Stifel from Bryan Garnier.
What are the expected financial benefits of Stifel’s acquisition of Bryan Garnier?
The acquisition is expected to enhance Stifel’s advisory capabilities and expand its market presence in Europe, potentially boosting revenue.
What was Stifel’s expected net revenue for 2024?
Stifel was on pace to generate over $4.8 billion in net revenue in 2024.
Who acted as the financial advisor for Stifel in the acquisition of Bryan Garnier?
Keefe, Bruyette & Woods acted as the exclusive financial advisor for Stifel.
Related
Molten leads €31M Series C In Deciphex’s pathology platform
Deciphex, an AI-powered digital pathology startup, has raised a €31M Series C round led by Molten Ventures. The round also featured s
Quantum Motion partners with GlobalFoundries to create more powerful chips
Computing scaleup Quantum Motion has partnered with semiconductor manufacturer GlobalFoundries to design and validate a new silicon chi
ClearScore snaps up Manchester-based Aro Finance in embedded finance move
A London-headquartered fintech that provides credit score services has snapped up a smaller Manchester fintech, as it expands into emb
NXP Semiconductors acquires TTTech Auto for $625M: a game changer…
NXP Semiconductors N.V is acquiring TTTech Auto in an all-cash transaction valued at $625 million. TTTech Auto, based in Vienna, Austri
